Literature DB >> 2053989

[Leiomyosarcoma of the larynx. Histological, immunohistochemical and ultrastructural study of a case with review of the literature].

P Bertheau1, A Deboise, A De Roquancourt, C Brocheriou.   

Abstract

Laryngeal leiomyosarcoma: histological, immunohistochemical and ultrastructural study of one case with review of the literature. Leiomyosarcoma of the larynx have rarely been reported and a review of the literature has yielded only 8 cases. Authors report a case in a 45-year-old patient. Histological exam of the surgical specimen showed a malignant spindle cell tumor. Ultrastructurally, neoplastic cells presented some features of smooth-muscle cells. Immunohistochemical studies revealed that most tumor cells coexpressed vimentin and smooth-muscle actin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2053989

Source DB:  PubMed          Journal:  Ann Pathol        ISSN: 0242-6498            Impact factor:   0.407


  5 in total

Review 1.  Laryngeal leiomyosarcoma: a case report and review of the literature.

Authors:  Charalambos E Skoulakis; Pelagia Stavroulaki; Panagiotis Moschotzopoulos; Mihalis Paxinos; Angela Fericean; Dimitris E Valagiannis
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-06-28       Impact factor: 2.503

2.  [Leiomyosarcoma of the larynx].

Authors:  P Gude; M Tisch; K Kraft; B Danz; H Maier
Journal:  HNO       Date:  2006-03       Impact factor: 1.284

3.  Leiomyosarcoma of the larynx.

Authors:  B M Lippert; E Schlüter; H Claassen; J A Werner
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

4.  Leiomyosarcoma of the upper oesophagus--a difficult pre-operative diagnosis.

Authors:  H Rowley; L Viani; E Leen; P Broe; T Keane
Journal:  Ir J Med Sci       Date:  1994-11       Impact factor: 1.568

5.  Prognostic factors for laryngeal sarcoma and nomogram development for prediction: a retrospective study based on SEER database.

Authors:  Jia Gu; Zhifan Zuo; Lei Sun; Li Li; Ning Zhao
Journal:  Ann Transl Med       Date:  2020-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.